搜索临床试验以:3 L PEG placebo
总计3142个结果
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)撤销III 期成人软组织肉瘤 | IV 期成人软组织肉瘤 | II 期成人软组织肉瘤 | IIA期成人软组织肉瘤 | IIB 期成人软组织肉瘤 | IIC 期成人软组织肉瘤
-
Tehran University of Medical Sciences完全的
-
University of Zurich完全的
-
UPECLIN HC FM Botucatu UnespFundação de Amparo à Pesquisa do Estado de São Paulo完全的爱滋病毒感染
-
Cerenis Therapeutics, SASouth Australian Health and Medical Research Institute完全的
-
Pierre Fabre MedicamentEurotrials Brasil Consultores Cientificos Ltda撤销
-
ImmuneBiotech Medical Sweden ABKarolinska Institutet完全的
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)完全的
-
Asan Medical CenterHanmi Pharmaceutical Company Limited完全的
-
University Hospital, Bordeaux完全的
-
Tehran University of Medical Sciences未知
-
University of WashingtonNational Cancer Institute (NCI)完全的先前治疗过的骨髓增生异常综合征 | 骨髓增生异常综合症 | 复发性急性髓性白血病 | 难治性急性髓性白血病 | 原始细胞过多的骨髓增生异常综合征 2 | 髓系肿瘤 | 慢性粒单核细胞白血病 2 | 破坏 10% 或更多的骨髓有核细胞 | 高级别恶性肿瘤美国
-
Shanghai Children's HospitalShanghai Children's Medical Center; BioGaia AB; Suzhou University Affiliated Children's Hospital未知
-
Frederiksberg University Hospital完全的
-
IBSA Farmaceutici Italia SrlUniversita degli Studi di Catania; Informapro Srl招聘中
-
Merck Sharp & Dohme LLC完全的
-
St. Jude Children's Research Hospital终止
-
National Cancer Institute (NCI)主动,不招人3a 级滤泡性淋巴瘤 | Ann Arbor III 期 1 级滤泡性淋巴瘤 | Ann Arbor III 期 2 级滤泡性淋巴瘤 | Ann Arbor IV 期 1 级滤泡性淋巴瘤 | Ann Arbor IV 期 2 级滤泡性淋巴瘤 | Ann Arbor III 期 3 级滤泡性淋巴瘤 | Ann Arbor IV 期 3 级滤泡性淋巴瘤美国